Recommendation ID
TA220/1
Question
NICE highlighted the importance of collecting further data within registries of patients receiving biological treatments for psoriatic arthritis to obtain information on long-term outcomes, including adverse events.
Any explanatory notes
(if applicable)
None.

Source guidance details

Comes from guidance
Golimumab for the treatment of psoriatic arthritis
Number
TA220
Date issued
April 2011

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No